Bourgeon Capital Management LLC Invests $2.74 Million in Cencora, Inc. $COR

Bourgeon Capital Management LLC bought a new stake in shares of Cencora, Inc. (NYSE:COR) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor bought 8,124 shares of the company’s stock, valued at approximately $2,744,000.

A number of other institutional investors and hedge funds have also recently modified their holdings of COR. United Bank grew its stake in shares of Cencora by 4.5% in the 2nd quarter. United Bank now owns 7,032 shares of the company’s stock worth $2,109,000 after buying an additional 305 shares in the last quarter. Northwestern Mutual Wealth Management Co. raised its position in shares of Cencora by 8.1% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 15,861 shares of the company’s stock valued at $4,756,000 after buying an additional 1,184 shares in the last quarter. Quadrature Capital Ltd purchased a new stake in shares of Cencora during the 2nd quarter valued at about $241,000. Lido Advisors LLC lifted its holdings in shares of Cencora by 23.0% in the 2nd quarter. Lido Advisors LLC now owns 7,956 shares of the company’s stock valued at $2,386,000 after acquiring an additional 1,487 shares during the last quarter. Finally, Edgestream Partners L.P. grew its position in Cencora by 1,348.2% in the second quarter. Edgestream Partners L.P. now owns 12,237 shares of the company’s stock worth $3,669,000 after acquiring an additional 11,392 shares in the last quarter. 97.52% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several equities research analysts have weighed in on COR shares. JPMorgan Chase & Co. boosted their price objective on Cencora from $417.00 to $419.00 and gave the stock an “overweight” rating in a research note on Tuesday, February 10th. Weiss Ratings raised Cencora from a “hold (c+)” rating to a “buy (b)” rating in a research note on Thursday, February 5th. Leerink Partners reiterated an “outperform” rating on shares of Cencora in a report on Tuesday, March 17th. Morgan Stanley set a $380.00 target price on Cencora in a research report on Tuesday, March 17th. Finally, Wells Fargo & Company increased their price target on Cencora from $405.00 to $429.00 and gave the company an “overweight” rating in a report on Tuesday, February 10th. Twelve investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to MarketBeat.com, Cencora currently has an average rating of “Moderate Buy” and an average target price of $403.17.

Insider Activity at Cencora

In other news, CEO Robert P. Mauch sold 5,096 shares of Cencora stock in a transaction that occurred on Tuesday, January 20th. The shares were sold at an average price of $354.73, for a total transaction of $1,807,704.08. Following the completion of the sale, the chief executive officer owned 66,726 shares of the company’s stock, valued at approximately $23,669,713.98. The trade was a 7.10% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Company insiders own 0.38% of the company’s stock.

Cencora Stock Up 1.3%

NYSE:COR opened at $313.88 on Wednesday. The company has a market cap of $61.06 billion, a price-to-earnings ratio of 37.73, a price-to-earnings-growth ratio of 1.44 and a beta of 0.68. Cencora, Inc. has a twelve month low of $267.40 and a twelve month high of $377.54. The company has a current ratio of 0.92, a quick ratio of 0.51 and a debt-to-equity ratio of 3.62. The stock has a fifty day simple moving average of $350.42 and a 200-day simple moving average of $341.25.

Cencora (NYSE:COR) last posted its quarterly earnings results on Wednesday, February 4th. The company reported $4.08 EPS for the quarter, topping analysts’ consensus estimates of $4.04 by $0.04. Cencora had a net margin of 0.50% and a return on equity of 176.54%. The firm had revenue of $85.93 billion for the quarter, compared to analysts’ expectations of $86.12 billion. During the same period in the prior year, the business posted $3.73 earnings per share. The business’s revenue for the quarter was up 5.5% on a year-over-year basis. Analysts anticipate that Cencora, Inc. will post 15.37 EPS for the current year.

Cencora Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Monday, March 2nd. Stockholders of record on Friday, February 13th were given a dividend of $0.60 per share. The ex-dividend date of this dividend was Friday, February 13th. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.8%. Cencora’s dividend payout ratio (DPR) is 28.85%.

Cencora Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.